← Browse by Condition
Medical Condition

cutaneous squamous cell carcinoma cscc

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT07064330
Recruiting

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Enrollment
30 pts
Location
Spain
Sponsor
Instituto de Investigación Bio...
View Trial →